Literature DB >> 24637981

A short neuropsychological evaluation of patients with primary Sjögren's syndrome.

Dóra-Neide Rodrigues1, João Sergio Ignácio Hora1, Maria Cecília Fonseca Salgado2, Renata Alves Paes1, Claudia Cristina Ferreira Vasconcelos1, J Landeira-Fernandez3, Regina Maria Papais Alvarenga4.   

Abstract

OBJECTIVE: To investigate cognitive deficits in patients with primary Sjögren's syndrome (PSS).
METHOD: Eighteen patients with PSS, aged between 25 and 61 years, were subjected to a short neuropsychological battery and compared with 18 patients with multiple sclerosis and 18 healthy controls.
RESULTS: The analysis of variance (ANOVA) revealed that the clinical groups had significantly worse performance than the control group on the Rey Auditory Verbal Learning Test 3; (F(2,53) =3.500, p=0.038) and 7 (F(2,53) =5.068, p=0.010). The clinical groups had elevated levels of depression on the Beck Depression Inventory (BDI); (p=0.003). The analysis of the data from the Trail Making Test B-A revealed a significant difference between the clinical and control groups (p=0.023). The analysis of covariance with BDI score as a covariate, did not change the outcome.
CONCLUSION: Our study revealed cognitive deficits in patients with PSS detectable by a short neuropsychological battery.

Entities:  

Mesh:

Year:  2014        PMID: 24637981     DOI: 10.1590/0004-282X20130195

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  2 in total

Review 1.  Depression and anxiety in dry eye disease: a systematic review and meta-analysis.

Authors:  K H Wan; L J Chen; A L Young
Journal:  Eye (Lond)       Date:  2016-08-12       Impact factor: 3.775

2.  Cognitive impairment in patients with Neuro-Sjögren.

Authors:  Tabea Seeliger; Lena Jacobsen; Merle Hendel; Lena Bönig; Nils K Kristian Prenzler; Thea Thiele; Diana Ernst; Torsten Witte; Martin Stangel; Bruno Kopp; Thomas Skripuletz
Journal:  Ann Clin Transl Neurol       Date:  2020-07-06       Impact factor: 4.511

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.